Capping enzyme
Capping Enzyme[edit | edit source]
The capping enzyme is a crucial component in the process of eukaryotic mRNA maturation. It is responsible for the addition of a 5' cap to the nascent pre-mRNA, a modification that is essential for mRNA stability, nuclear export, and efficient translation.
Structure and Function[edit | edit source]
The capping enzyme is a multifunctional protein complex that typically consists of several enzymatic activities:
- RNA triphosphatase: This enzyme removes the γ-phosphate from the 5' end of the nascent RNA, leaving a diphosphate group.
- Guanylyltransferase: This enzyme transfers a GMP moiety from GTP to the diphosphate end of the RNA, forming a 5' to 5' triphosphate linkage.
- Methyltransferase: This enzyme methylates the N7 position of the guanine cap, forming the characteristic 7-methylguanylate cap structure.
The 5' cap structure is recognized by specific cap-binding proteins, which play a role in mRNA processing and translation initiation.
Biological Significance[edit | edit source]
The 5' cap added by the capping enzyme serves several important functions:
- Protection from degradation: The cap structure protects mRNA from exonucleases that degrade RNA from the 5' end.
- Facilitation of nuclear export: The cap is recognized by the nuclear export machinery, allowing the mRNA to be transported from the nucleus to the cytoplasm.
- Promotion of translation: The cap is recognized by the eukaryotic initiation factor 4E (eIF4E), which is part of the translation initiation complex.
Regulation[edit | edit source]
The activity of the capping enzyme is tightly regulated and often coupled with transcription. The C-terminal domain (CTD) of RNA polymerase II plays a key role in recruiting the capping enzyme to the nascent RNA.
Clinical Relevance[edit | edit source]
Defects in the capping process can lead to various diseases, including certain types of cancer and genetic disorders. Understanding the capping mechanism is also important for the development of therapeutics and vaccines, as the cap structure can influence the stability and translation of mRNA-based treatments.
Also see[edit | edit source]
| Overview |
| ||||||
|---|---|---|---|---|---|---|---|
| Engineering |
| ||||||
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
